// App-Quantinova.ai

Su1075 : Colorectal Neoplasia Risk in Inflammatory Bowel Disease Accompanying Primary Sclerosing Cholangitis Depends on Disease Presentation

Researchers

Presenter

  • Hala Girgis

Principal Investigators

  • David F. Schaeffer

  • Lay Lay Win

  • Sara Hafezi-Bakhtiari

  • Maria Cino

  • Gideon M. Hirschfield

  • Hala El-Zimaity

Medical Centers

  • Universtiy Health Network, Toronto, ON, Canada

  • University of Toronto, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Primary sclerosing cholangitis

  • Inflammatory bowel disease

  • Colorectal Cancer

  • Ulcerative colitis

  • Ascending cholangitis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved